The Medical Industry Leadership Institute is proud to announce our Working Papers series. Carlson students have written these papers on topics relevant to today's medical industry. The series will represent a small portion of the work done by Carlson students, both past and present. All working papers are posted on our website. We hope that by posting papers we will not only stimulate discussion but also contribute to advancing our knowledge of the medical industry.
All papers have completed a review process prior to being posting, but full responsibility for the content of the paper remains with the author(s). Comments from readers are welcomed and should be sent directly to the author(s). Their views do not necessarily reflect those of the Medical Industry Leadership Institute. All papers are in PDF format.
On July 24, 2012, the Congressional Budget Office (CBO) released an updated analysis of the Medicare payment reductions included in the Affordable Care Act (ACA). Notably, this updated CBO estimate represents the first time that the Medicare payment reductions are accounted for in the full 10-year budget window. Totaling an estimated $716 billion between 2013 and 2022, the Medicare payment reductions comprise a majority of the Affordable Care Act's budgetary savings. However, the payment reductions are not uniformly distributed across the U.S. geography. To better understand the regional impact of the Medicare fee-for-service and Medicare Advantage payment reductions, we have revised and updated our earlier MILI working paper to reflect the state and county-level impacts based on the updated CBO estimate.
Use of Electronic Health Records (EHR) by American healthcare providers is accelerating, largely due to government regulations and incentives tied to 'Meaningful Use.' While evidence suggests EHRs improve the quality of care, 'Meaningful Use' guidelines have not, thus far, advanced a set of features that will truly realize the full potential of EHRs. In fact, published research suggests that featuring Clinical Decision Support (CDS) in EHRs is critical for the adoption of "evidence-based care" as well as the hoped-for quality and cost improvements, yet it is minimally represented in federal Meaningful Use guidelines. This paper discusses CDS in the context of Meaningful Use, suggesting policy adjustments that can further promote its widespread use in order to achieve the full potential of EHRs.